Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on: March 30,2024

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on:March 30,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on: April 22,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on:April 22,2024

Neurofeedback shows promise for addressing 'chemo brain' in pilot study

by University of California, Los AngelesCredit: CC0 Public DomainRestoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental foggine

Updated on: February 03,2024

Neurofeedback shows promise for addressing 'chemo brain' in pilot study

by University of California, Los AngelesCredit: CC0 Public DomainRestoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental foggine

Updated on:February 03,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on: February 03,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on:February 03,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on: July 05,2024

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Updated on:July 05,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Many owners see little value in storing their firearms securely, finds study

by Rutgers UniversityCredit: Unsplash/CC0 Public DomainWith more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized

Updated on: May 21,2024

Many owners see little value in storing their firearms securely, finds study

by Rutgers UniversityCredit: Unsplash/CC0 Public DomainWith more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized

Updated on:May 21,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on: November 10,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on:November 10,2024

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on: January 23,2024

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot

Updated on:January 23,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on: February 20,2024

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on:February 20,2024